How Do TB Drugs Interact With HIV Drugs?

How do TB drugs interact with HIV drugs? – In January, 2012, the US Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease. The drug rifampin, used for treating TB, can lower levels of the HIV medicine efavirenz, so the FDA recommended that patients who weigh more than 50 kg (110 pounds) and who are taking both medications should get 30 percent larger doses of efavirenz (an increase from 600 mg to 800 mg). Now, a new analysis by conducted by researchers with the Adult AIDS Clinical Trials Group (ACTG) at the University of California, San Francisco (UCSF) and the San Francisco General Hospital and Trauma Center (SFGH) suggests this recommended dose adjustment may not be necessary, particularly in non-Caucasian populations. As described in a talk at the XIX International AIDS Conference in Washington, DC on Monday, July 23, 2012, the new FDA guidelines were based on several small studies in European TB patients and one in healthy volunteers, indicating a decrease in efavirenz levels with rifampin. The guidelines were also informed by a mathematical model, which showed that increasing efavirenz to 800 mg when given with rifampin would increase levels to those seen on the regular dose of 600 mg. These data may not apply to patients in African and Asian populations because of genetic differences that lead to higher efavirenz levels …

Longtime pol Vargas readies for new D.C. post

Filed under: drug treatment programs washington dc

“I really believe that we as a society are going to be judged on how we treat the poor,” he said during a conversation at Golden Hill's Krakatoa coffee shop. “I think I can make a difference by standing up and saying we are not going to balance budgets …
Read more on North County Times (blog)

Use of Xarelto Expanded to Treat Blood Clots

Filed under: drug treatment programs washington dc

Washington, D.C. – infoZine – The U.S. Food and Drug Administration expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following …
Read more on Kansas City infoZine

Advocates Of Medical Marijuana Face Another Hurdle: Insurance Coverage

Filed under: drug treatment programs washington dc

Proponents of medical marijuana argue that research shows marijuana to be effective or show promise in treating a variety of medical problems, from cancer pain and nausea to spasticity caused by multiple sclerosis. They point to the drug Marinol, which …
Read more on PBS NewsHour (blog)